USRE48286E1 - Steroids as agonists for FXR - Google Patents

Steroids as agonists for FXR Download PDF

Info

Publication number
USRE48286E1
USRE48286E1 US16/448,503 US200216448503A USRE48286E US RE48286 E1 USRE48286 E1 US RE48286E1 US 200216448503 A US200216448503 A US 200216448503A US RE48286 E USRE48286 E US RE48286E
Authority
US
United States
Prior art keywords
compound
formula
ethyl
fxr
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US16/448,503
Inventor
Roberto Pellicciari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercept Pharmaceuticals Inc
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US27495901P priority Critical
Priority to US10/471,549 priority patent/US7138390B2/en
Priority to PCT/EP2002/001832 priority patent/WO2002072598A1/en
Priority to US16/448,503 priority patent/USRE48286E1/en
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23050302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE48286(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Assigned to INTERCEPT PHARMACEUTICALS, INC. reassignment INTERCEPT PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PELLICCIARI, ROBERTO
Assigned to INTERCEPT PHARMACEUTICALS reassignment INTERCEPT PHARMACEUTICALS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PELLICCIARI, ROBERTO
Publication of USRE48286E1 publication Critical patent/USRE48286E1/en
Application granted granted Critical
Assigned to U.S. BANK NATIONAL ASSOCIATION reassignment U.S. BANK NATIONAL ASSOCIATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INTERCEPT PHARMACEUTICALS, INC.
Assigned to INTERCEPT PHARMACEUTICALS, INC. reassignment INTERCEPT PHARMACEUTICALS, INC. CHANGE OF ADDRESS Assignors: INTERCEPT PHARMACEUTICALS, INC.
Assigned to INTERCEPT PHARMACEUTICALS, INC. reassignment INTERCEPT PHARMACEUTICALS, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 16488503 PREVIOUSLY RECORDED AT REEL: 060814 FRAME: 0702. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF ADDRESS. Assignors: INTERCEPT PHARMACEUTICALS, INC.
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links